Literature DB >> 12113032

Quality of life in patients with cancers of the upper gastrointestinal tract.

J M Blazeby1, C W Vickery.   

Abstract

Accurate assessment of health-related quality of life in patients with upper gastrointestinal cancers is essential to help determine treatment strategies. Questionnaires may be used to screen for physical and psychosocial morbidity, to evaluate new therapies and there is accumulating evidence to suggest that quality of life scores have prognostic value. There are well validated generic measures of quality of life suitable to use in patients with cancers of the upper gastrointestinal tract, but only two systems (EORTC QLQ-C30 and the FACT-G) have site-specific modules that have been constructed for this patient group. The future use of computer-assisted techniques to collect, analyze and interpret quality of life data will enable the implementation of quality of life results in clinical practice.

Entities:  

Mesh：

Year:  2001        PMID： 12113032     DOI： 10.1586/14737140.1.2.269

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  5 in total

1.  Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia.

Authors:  Krishdeep Singh Chadha; Michael Schiff; Michael D Sitrin; Gregory E Wilding; Hector Nava
Journal:  J Gastrointest Cancer       Date:  2010-09

2.  Ischemic conditioning shows a time-dependant influence on the fate of the gastric conduit after minimally invasive esophagectomy.

Authors:  Darmarajah Veeramootoo; Angela C Shore; Beverley Shields; Rakesh Krishnadas; Martin Cooper; Richard G Berrisford; Shahjehan A Wajed
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

3.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

4.  Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study.

Authors:  Sang Gyun Kim; Seon Mi Ji; Na Rae Lee; Seung-Hee Park; Ji Hye You; Il Ju Choi; Wan Sik Lee; Seun Ja Park; Jun Haeng Lee; Sang-Yong Seol; Ji Hyun Kim; Chul-Hyun Lim; Joo Young Cho; Gwang Ha Kim; Hoon Jai Chun; Yong Chan Lee; Hwoon-Yong Jung; Jae J Kim
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

5.  Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India.

Authors:  K Govind Babu; Tamojit Chaudhuri; K C Lakshmaiah; Lokanatha Dasappa; Linu Abraham Jacob; M C Suresh Babu; A H Rudresha; K N Lokesh; L K Rajeev
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.